Julliana Samson and other SNAP recipients are alarmed by the USDA's demand for their personal data. A federal lawsuit is challenging this unprecedented move, fearing misuse and privacy violations.
In a pivotal moment for the crypto world, President Trump has signed the GENIUS Act, creating a regulatory framework for stablecoins and drawing a sharp contrast with the Biden administration. This bipartisan legislation aims to bolster the crypto industry while addressing concerns over consumer protection and data privacy.
WeTransfer has clarified that it does not use uploaded files for AI training, responding to user concerns about recent terms of service changes. The company updated its clauses to better communicate its practices and avoid confusion among users.
President Trump has signed a 90-day extension for ByteDance to sell TikTok to an American buyer, ensuring the app remains operational for its 170 million US users. Will a deal finally happen?
In a surprising move, President Trump delays the enforcement of a bipartisan law that would ban TikTok in the U.S. for 90 days, citing ongoing negotiations with ByteDance. What does this mean for users and data privacy?
In a surprising turn, Anne Wojcicki's nonprofit, TTAM Research Institute, has acquired 23andMe for $305 million after its bankruptcy. This acquisition addresses concerns about genetic data privacy while aiming to uphold the company's mission.
Anne Wojcicki's nonprofit has won the bid to buy 23andMe, raising critical questions about the future of genetic data privacy. Experts warn that sensitive DNA information could be at risk.
In a surprising decision, the Supreme Court has sided with the Trump administration, allowing the Department of Government Efficiency (DOGE) to access sensitive data from the Social Security Administration amid ongoing legal challenges. This controversial ruling raises significant privacy concerns for millions of Americans.
Public distrust in the government, fueled by the Trump administration's data handling, is causing a decline in U.S. Census participation. Experts warn that this could lead to skewed statistics and affect federal funding allocations.
In a surprising turn of events, Regeneron has announced its acquisition of 23andMe for $256 million following the company's bankruptcy. The pharma giant aims to leverage 23andMe's vast customer data for drug discovery while prioritizing privacy and security.
